Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 606 is a nuclear transcription factor encoded by the ZNF606 gene in humans[1][4][6][8]. It contains an N-terminal Kruppel-associated box (KRAB) domain and multiple contiguous C2H2 zinc finger motifs, characteristic of a large family of transcriptional regulators[1][2][5]. ZNF606 acts as a transcriptional repressor, notably inhibiting growth factor-mediated signaling pathways and suppressing SRY-box 9 (SOX9) activity by preventing SOX9’s DNA binding[1][4][10]. Reduced expression of ZNF606 is linked to enhanced chondrocyte differentiation, suggesting a role in cartilage development[1][4]. Associated indirectly with adult hepatocellular carcinoma, its biological functions include gene silencing, regulation of cellular signaling pathways, and potentially influencing cellular differentiation and proliferation[1][4][9]. There is currently no evidence that ZNF606 is a direct therapeutic target or that drugs directly interact with it, and no specific safety or biomarker data are available.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 606 (ZNF606).